GLP 1 Receptor Agonists and Fat Hyperplasia

Send us Fan MailIn this episode, we explore the risks and scientific concerns surrounding GLP-1 receptor agonists, such as Wegovy and Zepbound, which are reshaping the weight loss and diabetes treatment markets. While these drugs show significant weight loss benefits, research reveals a troubling rebound effect when patients discontinue use, often leading to greater weight regain due to fat cell hyperplasia. Unlike the common yo-yo dieting effect, these medications can increase the number of fat cells in the body, making future weight management more challenging. Dr. Kiernan warns that without lasting lifestyle changes, users may face intensified fat accumulation, particularly in harmful visceral areas, exacerbating health risks. Are you eager to explore more about health and wellness? Discover an all natural solution to combating the GLP-1 Receptor Agonist craze. Click on the link below and explore the Feel Great System - a clinically proven approach to boosting natural GLP-1 production, suppressing appetite and improving both your metabolism and weight.https://ufeelgreat.com/usa/en/c/LiveFreeAs a Decoding Health viewer, you get wholesale pricing and a money back guarantee. Give it a try and let us know your results.https://imbiopharma.com/https://www.linkedin.com/in/urban-a-kiernan-ph-d-8568b621/https://www.youtube.com/@DecodingHealthPodcastThank you to our sponsor - iMetabolic Biopharma Corporation: Together, we can be the next stage in developing a revolutionary approach to drug discovery.  We give communities the opportunity to invest in their own health as we improve how drugs are discovered to make them more effective and affordable. Visit https://imbiopharma.com/ to learn more.This show is proudly produced at PS Studios — learn more https://www.psstudios.co